These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12909310)

  • 41. Hyperhomocysteinemia and macromolecule modifications in uremic patients.
    Perna AF; Capasso R; Lombardi C; Acanfora F; Satta E; Ingrosso D
    Clin Chem Lab Med; 2005; 43(10):1032-8. PubMed ID: 16197294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High homocysteine levels prevent via H2 S the CoCl2 -induced alteration of lymphocyte viability.
    Bruzzese L; Fenouillet E; Fromonot J; Durand-Gorde JM; Condo J; Kipson N; Mottola G; Deharo P; Guieu R; Ruf J
    J Cell Mol Med; 2016 Aug; 20(8):1411-9. PubMed ID: 27061011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Homocysteine and arterial occlusive disease: a concise review.
    Andreotti F; Burzotta F; Mazza A; Manzoli A; Robinson K; Maseri A
    Cardiologia; 1999 Apr; 44(4):341-5. PubMed ID: 10371785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone.
    Herrmann M; Tami A; Wildemann B; Wolny M; Wagner A; Schorr H; Taban-Shomal O; Umanskaya N; Ross S; Garcia P; Hübner U; Herrmann W
    Bone; 2009 Mar; 44(3):467-75. PubMed ID: 19056526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proceedings of the Fourth Conference on Hyperhomocysteinemia. Saarbrücken, Germany. April 14-16, 2005.
    Clin Chem Lab Med; 2005; 43(10):977-1169. PubMed ID: 16320456
    [No Abstract]   [Full Text] [Related]  

  • 46. Determinants of the S-adenosylhomocysteine (SAH) technique for the local assessment of cardiac free cytosolic adenosine.
    Loncar R; Flesche CW; Deussen A
    J Mol Cell Cardiol; 1997 May; 29(5):1289-305. PubMed ID: 9201616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homocysteine and oxidative stress.
    Perna AF; Ingrosso D; De Santo NG
    Amino Acids; 2003 Dec; 25(3-4):409-17. PubMed ID: 14661100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Homocysteine and hyperhomocysteinemia].
    Laskowska-Klita T
    Pol Merkur Lekarski; 2001 Mar; 10(57):135-7. PubMed ID: 11398509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hyperhomocysteinemia in patients with cardiovascular disease].
    Baszczuk A; Kopczyński Z
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():579-89. PubMed ID: 24864108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo elevation of mouse brain S-adenosyl-L-homocysteine after treatment with L-homocysteine.
    Gharib A; Chabannes B; Sarda N; Pachéco H
    J Neurochem; 1983 Apr; 40(4):1110-2. PubMed ID: 6834042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homocysteine in neurological disease: a marker or a cause?
    Khanna S; Kapoor P; Pillai KK; Vohora D
    CNS Neurol Disord Drug Targets; 2011 May; 10(3):361-9. PubMed ID: 20874694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperhomocysteinemia and lower extremity wounds.
    Schwartzfarb EM; Romanelli P
    Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.
    Suliman ME; Lindholm B; Bárány P; Bergström J
    Clin Chem Lab Med; 2001 Aug; 39(8):734-8. PubMed ID: 11592443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of 9-beta-D-arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine on the metabolism of S-adenosylhomocysteine, S-adenosylmethionine, and adenosine in rat liver.
    Eloranta TO; Kajander EO; Raina AM
    Med Biol; 1982 Oct; 60(5):272-7. PubMed ID: 7154718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A new strategy to treat hyperhomocysteinemia].
    Geng B; Chang L; Du JB; Tang CS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):215-9. PubMed ID: 15841160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HOMOCYSTEINE AND CARDIOVASCULAR DISEASE - A CURRENT REVIEW.
    Gospodarczyk A; Marczewski K; Gospodarczyk N; Widuch M; Tkocz M; Zalejska-Fiolka J
    Wiad Lek; 2022; 75(11 pt 2):2862-2866. PubMed ID: 36591781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chronic complication of diabetes and homocysteine].
    Idzior-Waluś B; Cieślik G
    Przegl Lek; 2000; 57(12):732-5. PubMed ID: 11398598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats.
    Sharma M; Rai SK; Tiwari M; Chandra R
    Eur J Pharmacol; 2007 Nov; 574(1):49-60. PubMed ID: 17706635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
    Caramia G; Belardinelli R
    Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Moderate hyperhomocysteinemia and cardiovascular disease.
    Tsai MY
    J Lab Clin Med; 2000 Jan; 135(1):16-25. PubMed ID: 10638690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.